跳至主要内容
临床试验/NCT06173141
NCT06173141已完成不适用

Effect of Intradialytic Continuous Versus Interval Aerobic Exercises on Functional Capacity Quality of Life and in Patients With Chronic Renal Failure.

Cairo University2 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2022年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
67
试验地点
2
主要终点
Kidney Disease Quality of Life Questionnaire -SF36(KDQoL-SF36)

研究概览

简要总结

Chronic kidney disease has emerged as one of the leading causes of mortality worldwide, and it is one of a small number of non-communicable diseases that have shown an increase in associated deaths over the past 2 decades. The high number of affected individuals and the significant adverse impact of chronic kidney disease should prompt enhanced efforts for better prevention and treatment.

Chronic kidney disease is a serious medical problem, as it is associated with high risks of complications which lead to poor quality of life and physical capacity.

详细描述

Sixty-seven patients undergoing haemodialysis randomly be allocated into three groups, (A, B & C). Group A (low- to moderate-continuous intensity cycling exercises, group B (moderate- to high-interval intensity cycling exercises), the exercises performed two sessions per week for two months and group (C)Twenty three patients received the hemodialysis sessions only.

Group A (low- to moderate-continuous intensity cycling exercises:

Twenty three patients performed aerobic exercise during dialysis using Pedal machine at low- to moderate continuous intensity rating from 11 to 13 on the Borg scale for 15-30 minutes.

warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities.

Group B (moderate- to high-interval intensity cycling exercises), Twenty one patients performed aerobic exercise during dialysis using Pedal machine at moderate-to-high interval intensity rating from 12 to 15 on the Borg scale for 15-30 minutes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

single (participant)

入排标准

年龄范围
35 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Sixty-seven patients of both sexes
  • Age will range from 35-55 years old.
  • BMI will be from 25-34.5 Kg/m
  • All patients with stage 5 of CRF.
  • All patients are stable on dialysis for at least six months before the study.
  • Stable medical and clinical hemodynamic state.

排除标准

  • Patients with hearing impairment or mental disorder.
  • Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
  • Patients with auto-immune diseases.
  • Chronic inflammatory orthopedic disorders and rheumatoid arthritis.
  • Patients with history of neuromuscular disease (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
  • Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
  • Patients with BMI > 35Kg/m2.

结局指标

主要结局

Kidney Disease Quality of Life Questionnaire -SF36(KDQoL-SF36)

时间窗: pre and post treatment after 2 months

The KDQOL™-36 contains 5 subscales: The Physical Component Summary (PCS), Mental Component Summary (MCS), Burden of Kidney Disease (BKD), Symptoms and Problems of Kidney Disease (SPKD), and Effects of Kidney Disease (EKD). The first 2 subscales are a generic measure of HRQOL (and are identical to the SF-12), whereas the last 3 assess issues specific to patients with ESRD or earlier stages of chronic kidney disease.

次要结局

  • blood urea, serum creatinine(pre and post treatment after 2 months)
  • 6-min walk distance(pre and post treatment after 2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heba Ahmed Mousa Galeb

Lecturer at the Department of Physical Therapy for Cardiovascular /Respiratory Disorders and Geriatrics Faculty of Physical Therapy

Cairo University

研究点 (2)

Loading locations...

相似试验

Effect of Intradialytic Continuous Versus Interval... | 临床试验